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INTRODUCTION
Aberrant methylation patterns are one of the fundamental
hallmarks of cancer cells. Tumor cells are generally hypomethy-
lated relative to normal cells with regional hypermethylation.
CpG islands are GC-rich areas of the genome corresponding to
the promoter regions of genes and are associated with transcrip-
tional activity (1). The methylation status of these CpG islands
has been shown to be involved with oncogene activation and
tumor suppressor gene inactivation. A recent study on the
profile of promoter hypermethylation for 12 genes (p16INK4A,
p15INK4B, p14ARF, p73, APC, BRCA1, hMLH1, GSTP1, MGMT,
CDMI, TIMP3, and DAPK) in 15 major tumor types revealed
that one or more of the genes are hypermethylated in all tumor
types (2). The profile of the promoter hypermethylation for
the genes, however, differs in each cancer type, providing a
tumor type- and gene-specific profile. 
Aberrant methylation in tumor-related genes is frequently
detected in gastric intestinal metaplasia with and without
gastric cancer, suggesting their early involvement in the mul-
tistep progression of gastric carcinogenesis (3). The identifi-
cation of genes targeted by hypermethylation may provide
insights into the mechanisms for the inactivation of tumor-
suppressive pathways in gastric cancer cases. In addition,
hypermethylated genes may serve as targets for the develop-
ment of new screening tests for cancer (4). 
In the present study, we compared the hypermethylation of
genes responsible for the cell repair system (hMLH1, MGMT,
and GSTP1) in gastric cancer case and control study. We also
analyzed MINT 25 (methylated in tumors 25) which showed
a high frequency of methylation in gastric carcinomas (5, 6).
There are many reports that have shown frequent hyperme-
thylation of these genes in gastric carcinoma, but its inter-
action with histological characteristics is still unclear. Thus,
we evaluated the association between the hypermethylation
of these genes and gastric cancer according to the risk factors
such as H. pylori infection, alcohol consumption, smoking,
family history, and their histological characteristics by the
methylation-specific PCR (MSP) method. 
MATERIALS AND METHODS
Subjects and genomic DNA purification
A case-control study of gastric cancer was performed in
Daegu City. One hundred gastric cancer patients and two
hundred thirty-eight healthy subjects participated in this
study. Patients affected with gastric cancer were considered
eligible if they had histologically diagnosed adenocarcinoma
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DNA Hypermethylation of Tumor-Related Genes in Gastric Carcinoma
The hypermethylation of the CpG islands is a common mechanism for the inacti-
vation of tumor-related genes. In the present study, we analyzed the methylation
status of genes for cell repair such as hMLH1, MGMT, and GSTP1, and a gastric
cancer-specifically methylated DNA fragment, MINT 25 in gastric cancer cases
and control groups. The study population consisted of 100 gastric cancer patients
(50 distal and 50 proximal carcinomas), and 238 healthy controls. All genes showed
more frequent hypermethylation in the cases than in the control group (p<0.0001).
We investigated the association between promoter hypermethylation and relevant
parameters including age, gender, alcohol consumption, smoking, and family his-
tory. There was a common hypermethylation of hMLH1 (p=0.008), MGMT (p=
0.0001), and GSTP1 (p=0.0003) in females. This study also demonstrates that
hypermethylation was strongly associated with non-drinkers (MGMT, p=0.046 and
MINT 25, p=0.049) and non-smokers (hMLH1, p=0.044; MGMT, p=0.0003; MINT
25, p=0.029). Moreover, the frequency of MINT 25 hypermethylation increased
with age (p=0.037), and MGMT methylation was frequently detected in distal gas-
tric cancer than in proximal type (p=0.038). Our study suggested that promoter
hypermethylation of the genes involved in cell repair system and MINT 25 is asso-
ciated strongly with some subgroups of primary gastric carcinoma.
Key Words : Stomach Neoplasms; DNA Methylation; MLH1 Protein, mammalian; O (6)-Methylguanine-DNA
Methyltransferase; Glutathione S-transferase pi; MINT 25
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of the stomach. The control group included subjects who
had no current or previous diagnosis of cancer. Data includ-
ed questionnaire data, and a review of medical records. 
Whole blood samples of control group were used to iso-
late genomic DNA by the phenol-chloroform method (7).
Tumor tissues were used to determine DNA methylation
status of cancer patients. Frozen tumor tissues were ground
and incubated at 50℃ for 3 hr in a lysis buffer containing
0.5% of sodium dodecyl sulfate (SDS), followed by a phenol-
chloroform method. The amount of DNA and their purity
were determined by spectrophotometry.  
Bisulfite modification 
DNA methylation patterns in the CpG islands of the tar-
get genes were determined by chemical modification of un-
methylated, but not methylated, cytosines to uracils, and
subsequent PCR amplification using primers specific for
either methylated or modified unmethylated DNA (8). The
bisulfite-modification was performed according to Olek et
al. (9). One microgram of DNA was denatured by NaOH
and modified by sodium bisulfite. DNA samples were then
purified using Wizard DNA purification resin (Promega,
Madison, WI, U.S.A.), treated with NaOH again, and pre-
cipitated with ethanol. DNA was resuspended in water and
used immediately or stored at -20℃. 
Methylation-sensitive PCR and bisulfite-PCR RFLP
Two  L of treated DNA were used for each PCR reaction.
MSP showed the presence or absence of methylated genes of
hMLH1, MGMT, and GSTP1. The methylation status of
MINT 25 was determined by bisulfite-PCR followed by res-
triction digestion. Two  L of DNA modified with bisulfite
were amplified and 15  L of the PCR products were then
digested with RsaI, which is specific to the methylated alleles
by virtue of having CpG sites in their recognition sequence.
After digestion, 10  L of each product were directly loaded
onto 2% agarose or 6% polyacrylamide gels and stained with
ethidium bromide. Primer sequences and annealing temper-
atures are shown in Table 1.
Statistical analysis 
Cases and controls were described according to their basic
sociodemographic, and clinicopathological factors. Patients
who indicated that they had stopped smoking or drinking
alcohol within the post 6 months were classified as current
smokers or current alcohol drinkers.  2 tests and Fisher’s exact
tests were done using the software package SAS Release 8.01
for Windows to examine the differences in DNA methylation
status. The corresponding tests on the cases and controls were
carried out (p-values) to compare each factor. 
RESULTS
DNA methylation in gastric carcinoma
We determined aberrant DNA methylation of hMLH1,
Anneal-
ing Temp
(℃)
Size
(bp)
Gene M/U Sequences (5 � 3 )
S/
AS
MGMT MS TTTCGACGTTCGTAGGTTTTCGCGC 81 59
AS ACTCTTCCGAAAACGAAACG
US TTTGTGTTTTGATGTTTGTAGGTTTTTGT 93 59
AS AACTCCACACTCTTCCAAAAACAAAACA
hMLH1 MS ACGTAGACGTTTTATTAGGGTCGC 124 60
AS CCTCATCGTAACTACCCGCG
US TTTTGATGTAGATGTTTTATTAGGGTTGT112 60
AS ACCACCTCATCATAACTACCCACA
GSTP1 M S TTCGGGGTGTAGCGGTCGTC 91 59
AS GCCCCAATACTAAATCACGAC
U S GATGTTTGGGGTGTAGTGGTTGTT 97 59
AS CCACCCCAATACTAAATCACAACA
MINT25 S TYGGTGTTTGTAAAGGGTTGGAAT 233 60
AS CCCRAACTAAAAACTAACTCRTAA
Table 1. PCR primers used for MSP and bisulfite-PCR
′′
Fig. 1. Methylation analysis in gastric cancer. (A) hMLH1, (B) MGMT,
and (C) GSTP1 methylation were analyzed by methylation-specific
PCR. The presence of visible PCR products in those lanes marked
U indicate the presence of unmethylated genes; the presence of
products in those lanes marked M indicate the presence of methy-
lated genes. Cases 9, 35, 59, and 92 show methylated and un-
methylated bands because of the heterogeneously methylated
genes, and cases 5 and 75 do not have methylated genes. (D)
MINT 25 methylation analysis was performed by bisulfite-PCR and
restriction digestion. Only methylated alleles will be digested by
restriction enzymes, and they are indicated by arrows. Case 27
and 28 have homogeneously and, heterogeneously methylated
MINT 25 DNA fragments, respectively. 
Case 92
U M
Case 75
U M
Case 9
U M
Case 35
U M
Case 5
U M
Case 59
U M
Cases
25       26       27       28
A B
C D
M, methylated; U, unmethylated; S, sense; AS, antisense.238 S.H. Hong, H.G. Kim, W.B. Chung, et al.
MGMT, MINT 25, and GSTP1 in 100 gastric cancer patients
and 238 randomly chosen, healthy Koreans. The mean ages
were 62 yr for cancer patients and 60.7 yr for controls. These
genes were generally unmethylated in the control group, in
particular, MINT 25 and GSTP1 showed no hypermethyla-
tion. All these genes, however, were aberrantly methylated
in the cancer group at the following frequencies: 26 (26%)
for hMLH1, 25 (25%) for MGMT, 19 (19%) for MINT 25,
and 7 (7%) for GSTP1. All the pvalues are <0.0001, and the
overall results are shown in Fig. 1 and Table 2. When we com-
pared the relationship of the DNA methylation of hMLH1 and
other 3 genes, we found concurrent methylation of hMLH1
and any of other 3 genes (p=0.045) (Table 3).
Association between the characteristics of patients and
DNA methylation
We analyzed the methylation changes in the tumors and
the questionnaire data obtained from the patients. The pro-
moter hypermethylation of hMLH1, MGMT, and GSTP1
were detected more frequently in women than in men and
the frequencies are as follows: 44.4% vs. 15.6% for hMLH1
(p=0.008), 50.0% vs. 10.9% for MGMT (0.0001), and 13.9%
vs. 3.1% for GSTP1 (p=0.0003). To determine the relation-
ship between DNA hypermethylation and aging, we ranked
the 100 gastric carcinomas into three groups according to
age. The proportion of MINT 25 methylation was increased
with age (p=0.037). We compared the frequency of methy-
lation after grouping the cases in two by tobacco smoking
or never-smoking. It is interesting to note that the promot-
er hypermethylation of MGMT and MINT 25 were detect-
ed less frequently in the alcohol consumption subgroup and
the frequencies are as follows: 14.6% vs. 32.2% for MGMT
(p=0.046), and 9.8% vs. 25.4% for MINT 25 (p=0.049).
When we compared the methylation after grouping in two
by smoking or never smoking, we observed similar results
in alcohol consumption, which showed a lower proportion
hMLH1 methylation (18.6% vs. 36.6%, p=0.044), MGMT
(11.9% vs. 43.9%, p=0.0003), and MINT 25 (11.9% vs.
29.3%, p=0.029). There was no significant difference in the
methylation frequency between subgroups with and with-
out gastric cancer family history. The proportion of hMLH1
methylation in these two groups was 27.6% and 15.4%, res-
pectively, but it is not statistically significant. 
Another aim of this study was to investigate that the ins-
tances of promoter hypermethylation in gastric carcinoma
are associated with histological parameters such as H. pylori
infection, tumor location, and Lauren classification. In our
study, MGMT showed hypermethylation more frequently
in distal gastric carcinomas than in the proximal type (34%
vs. 16%, p=0.038). These were summarized in Table 4.
DISCUSSION
Methylation of the CpG islands of tumor suppressor genes
Frequency of hypermethylation (%)
hMLH1 MGMT MINT 25 GSTP1
Cases (n=100) 26 (26.0)* 25 (25.0)* 19 (19.0)* 7 (7.0)*
Controls (n=238) 2 (0.8) 4 (1.7) 0 (0) 0 (0)
*All the p values are <0.0001.
Table 2. The frequency of DNA hypermethylation in gastric can-
cer and control groups
hMLH1 Concurrent methylation (any genes)
Methylated  (n=26) 16 (61.6%)*
Unmethylated (n=74) 23 (31.1%)
*p=0.045.
Table 3. Concurrent hypermethylation of hMLH1 with other genes
*Current or ex-drinkers, 
� Current or ex- smokers, 
� One or more first-degree
relatives with gastric cancer, 
�p values by chi square test, 
‖p values by
Fisher’s exact test.
Frequency of hypermethylation (%)
hMLH1 MGMT MINT 25 GSTP1 Any genes 
Variables n
Sex
Female 36 16 (44.4)
� 18 (50.0)
� 8 (27.8) 5 (13.9)
‖ 28 (77.8)
Male 64 10 (15.6) 7 (10.9) 9 (14.1) 2 (3.1) 23 (35.9)
p values p=0.008 p=0.0001 p=0.0003 p=0.037
Age (yr)
<60 37 5 (13.5)  10 (25.6) 5 (12.8)
� 3 (7.7) 18 (46.2)
60-69 38 13 (34.2) 9 (25.0) 5 (13.9) 3 (8.3) 17 (47.2)
>69  25 8 (32.0) 6 (24.0) 7 (28.0) 1 (4.0) 15 (60.0)
p values p=0.037
Alcohol consumption
Yes* 41 8 (19.5) 6 (14.6)
� 4 (9.8)
� 2  (4.9) 16 (37.2)
No 59 18 (30.5) 19 (32.2) 15(25.4) 5 (8.5) 34 (59.6)
p values p=0.046 p=0.049
Smoking
Yes
� 59 11 (18.6)
� 7 (11.9)
� 7 (11.9)
� 2 (3.4) 20 (32.3)
No 41 15 (36.6) 18 (43.9) 12 (29.3) 5 (12.2) 30 (78.9)
p values p=0.044 p=0.0003 p=0.029
Family history
�
Yes 87 24 (27.6) 20 (23.0) 16 (18.3) 6 (6.9) 42 (49.4)
No 13 2 (15.4) 5 (38.5) 3 (23.1) 1 (7.7) 9 (60.0)
Histological characteristics
H. pylori infection
Yes 63 19 (30.2) 17 (27.0) 15 (23.8) 3 (4.8) 33 (51.6)
No 37 7 (18.9) 8 (21.6) 4 (10.8) 4 (10.8) 16 (44.4)
Location
Distal 50 12 (24.0) 17 (34.0)
� 12 (24.0) 2 (4.0) 29 (58.0)
Proximal 50 14 (28.0) 8 (16.0) 7 (14.0) 5 (10.0) 22 (44.0)
p values p=0.038
Lauren classification
Intestinal 32 9 (28.1) 8/30 (25.0) 8 (25.0) 2 (6.3) 18 (60.0)
Mixed 22 5 (26.7) 4/22 (18.2) 1 (4.6) 4 (18.2) 9 (40.9)
Diffuse 46 12 (22.1)13/45 (28.3) 10 (21.7) 1 (2.2) 23 (51.1)
Table 4. Association between the characteristics of the subjects
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leading to their transcriptional inactivation is a highly con-
sistent feature of tumorigenesis. In the present study, we
demonstrated the distribution pattern of the aberrant methy-
lation of hMLH1, MGMT, MINT 25 and GSTP1 in gastric
cancer patients and controls. We also investigated the asso-
ciation between promoter hypermethylation and relevant
parameters including age, gender, alcohol consumption, smok-
ing, and family history. Other histological characteristics were
also taken into consideration. 
The transcriptional inactivation of MGMT by DNA methy-
lation occurs in a wide spectrum of human tumors (10), where-
as that of hMLH1 is restricted to sporadic tumors with micro-
satellite instability such as colon (11), endometrial (12, 13),
and gastric tumors (14). MGMT plays a major role in the
repair of O6-methylguanine DNA adducts. The loss of MGMT
expression is rarely due to genetic mutation, but due to the
methylation of discrete regions of the CpG island of the gene.
Recently reported data indicated that MGMT protein expres-
sion levels were decreased by the promoter hypermethylation
of MGMT in gastric carcinomas (15). Glutathione S-trans-
ferases (GSTs) are a family of enzymes involved in the detoxi-
cation of xenobiotics and oxygen radicals (16, 17). Recent
studies have demonstrated that the expression of the GSTP1
gene, one of the GST isoenzymes, is controlled by DNA methy-
lation (18). MINT 25 stands out as the specific methylation
pattern in gastric tumors, and there was no methylation ob-
served in either normal stomach or colon, or less than 10%
of colorectal tumors (19). This suggests that it may play a
special role in stomach neoplasia.
In the present study, the methylation of hMLH1, MGMT,
MINT 25, and GSTP1 in gastric cancer was detected more
frequently than in the controls (p<0.0001). Previous report
showed that concurrent hypermethylation of hMLH1, CDH1,
MGMT and COX2 gene promoters was more frequently ob-
served in MSI-H gastric tumors, and the significant associa-
tion between the concurrent hypermethylation and MSI-H
was lost when hMLH1 was excluded (20). We tried to com-
pare the hypermethylation pattern between hMLH1 and
other genes analyzed in this study. Our result indicates that
concurrent hypermethylation of hMLH1 and the other three
genes are a common event in gastric cancer (p=0.045). Further
studies are necessary to determine the association between
the inactivation of hMLH1 gene promoters by hypermethy-
lation and the microsatellite instability status of gastric car-
cinomas. 
We investigated the association between promoter hyper-
methylation and relevant parameters including age, gender,
alcohol consumption, smoking, and family history. We found
that the promoter hypermethylation of hMLH1, MGMT,
and GSTP1 was detected more frequently in women than
in men (p<0.05). A previous report showed that the methy-
lation of TIMP-3 was seen more frequently in women with
lung cancer, whereas methylation of DAPK and p16INK4a was
more common in men. These data suggest that some genes
showed gender-specific methylation pattern, but the reason
for this is unknown. 
It has been described that aging is associated with the methy-
lation of certain genes such as hMLH1 (21) and estrogen re-
ceptor (22). In the present study the proportion of MINT
25 methylation increased with age (p=0.037), and hMLH1
also showed significant difference of methylation frequency
between the two age groups of 69 yr apart. Previous studies
showed that age-related methylation affects only a subset of
genes, suggesting a gene-specific susceptibility in this pro-
cess (23). Furthermore, there are significant tissue-specific
differences in age-related methylation (23). MINT 25, which
is strongly associated with gastric carcinoma, demonstrated
for the first time in this report an age dependent methyla-
tion pattern. 
In the present study, there was a significant association bet-
ween methylation and smoking/alcohol consumption. The
proportion of promoter methylation of genes increased sig-
nificantly in the never-smoking or never-drinking subgroups
(p<0.05). It was also shown that the incidence of MGMT pro-
moter hypermethylation was significantly higher in never-
smokers in lung adenocarcinomas (24). These result are, how-
ever, inconsistent with the previous study related with the
promoter methylation pattern of tumor suppressor genes in
head and neck squamous cell carcinoma (25). It could be
suggested that hypermethylation is regulated differently by
alcohol consumption and/or smoking in genes. 
There was a difference in hMLH1 methylation between
subgroups with and without family history of gastric carci-
noma, but this is not statistically significant. Since the size
of these two subgroups is significantly different, it needs fur-
ther investigation with more subgroups without gastric can-
cer family history.
A previous study showed that the p16 methylation in the
distal stomach epithelium was higher than that in the proxi-
mal stomach (26). There have been reports showing that the
microsatellite instability phenotype is linked with promoter
hypermethylation of hMLH1 and MGMT (27). Furthermore,
many studies including with Korean patients showed that
gastric cancer with microsatellite instability was associated
with distal location (28-31). These reports suggest that hyper-
methylation is more susceptible in distal gastric carcinoma.
The correlation mechanism between the microsatellite insta-
bility and DNA methylation needs to be uncovered. In our
study, MGMT hypermethylation was detected more fre-
quently in distal gastric carcinoma than in the proximal type
(p=0.038). 
A previous report suggested that there was a significant
association between hMLH1 promoter hypermethylation and
intestinal type gastric carcinomas (32). Another study, how-
ever, showed that the frequency of hMLH1 methylation was
similar between intestinal and diffuse type gastric carcinomas
(3). In our study, there was no association between hMLH1
hypermethylation and the Lauren classification of gastric240 S.H. Hong, H.G. Kim, W.B. Chung, et al.
carcinomas. 
In conclusion, our study regarding promoter hypermethy-
lation of genes involved in the cell repair system and MINT
25 in primary gastric carcinomas shows the high frequency of
methylation of hMLH1, MGMT, and MINT 25. This study
also demonstrates that hypermethylation was strongly asso-
ciated with females, and non-drinking/non-smoking sub-
groups. Moreover, the frequency of MINT 25 hypermethy-
lation increased with aging, and the methylation of MGMT
was frequently detected in distal gastric cancer than in proxi-
mal cancer. The exact nature of the methylation defect in can-
cer cells should be defined by further studies. 
ACKNOWLEDGEMENT
This research was supported by research grants from Catholic
University of Daegu in 2002.
REFERENCES
1. Bird AP. CpG-rich islands and the function of DNA methylation.
Nature 1986; 321: 209-13.
2. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethyla-
tion profile of human cancer. Cancer Res 2001; 61: 3225-9.
3. To KF, Leung WK, Lee TL, Yu J, Tong JH, Chan MW, Ng EK,
Chung SC, Sung JJ. Promoter hypermethylation of tumor-related
genes in gastric intestinal metaplasia of patients with and without
gastric cancer. Int J Cancer 2002; 102: 623-8.
4. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno
G, Gabrielson E, Baylin SB, Herman JG. Aberrant methylation of
p16(INK4a) is an early event in lung cancer and a potential biomark-
er for early diagnosis. Proc Natl Acad Sci USA 1998; 95: 11891-6.
5. Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin
SB, Issa JP. Aberrant methylation in gastric cancer associated with
the CpG island methylator phenotype. Cancer Res 1999; 59: 5438-
42.
6. Oue N, Oshimo Y, Nakayama H, Ito R, Yoshida K, Matsusaki K,
Yasui W. DNA methylation of multiple genes in gastric carcinoma:
Association with histological type and CpG island methylator phe-
notype. Cancer Sci 2003; 94: 901-5.
7. Sambrook J, Fritsch EF, Maniatis T. Isolation of high-molecular-
weight DNA from mammalian cells. In: Sambrook J, Fritsch EF,
Maniatis T (ed.), Molecular cloning: A laboratory manual, 2nd eds.,
Cold spring harbor, New York: Cold Spring Harbor Lab. Press, 1989;
9.16-9.22.
8. Wang RY, Gehrke CW, Ehrlich M. Comparison of bisulfite modifi-
cation of 5-methyldeoxycytidine and deoxycytidine residues. Nucle-
ic Acids Res 1980; 8: 4777-90.
9. Olek A, Oswald J, Walter J. A modified and improved method for
bisulphite based cytosine methylation analysis. Nucleic Acids Res
1996; 24: 5064-6.
10. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inac-
tivation of the DNA repair gene O
6-methylguanine-DNA methyltrans-
ferase by promoter hypermethylation is a common event in primary
human neoplasia. Cancer Res 1999; 59: 793-7.
11. Wheeler JM, Beck NE, Kim HC, Tomlinson IP, Mortensen NJ, Bod-
mer WF. Mechanisms of inactivation of mismatch repair genes in
human colorectal cancer cell lines: the predominant role of hMLH1.
Proc Natl Acad Sci USA 1999; 96: 10296-301.
12. Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG. MLH1
promoter hypermethylation is associated with the microsatellite insta-
bility phenotype in sporadic endometrial carcinomas. Oncogene 1998;
17: 2413-7.
13. Esteller M, Catasus L, Matias-Guiu X, Mutter GL, Prat J, Baylin SB,
Herman JG. hMLH1 promoter hypermethylation is an early event in
human endometrial tumorigenesis. Am J Pathol 1999; 155: 1767-72.
14. Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou
TT, Abraham JM, Kong D, Smolinski KN, Shi YQ, Rhyu MG, Pow-
ell SM, James SP, Wilson KT, Herman JG, Meltzer SJ. Hypermethy-
lation of the hMLH1 gene promoter in human gastric cancers with
microsatellite instability. Cancer Res 1999; 59: 1090-5.
15. Oue N, Shigeishi H, Kuniyasu H, Yokozaki H, Kuraoka K, Ito R,
Yasui W. Promoter hypermethylation of MGMT is associated with
protein loss in gastric carcinoma. Int J Cancer 2001; 93: 805-9.
16. Pickett CB, Lu AY. Glutathione S-transferases: gene structure, regu-
lation, and biological function. Annu Rev Biochem 1989; 58: 743-64.
17. Tsuchida S, Sato K. Glutathione transferases and cancer. Crit Rev
Biochem Mol Biol 1992; 27: 337-84.
18. Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova
GS, Hsieh WS, Isaacs WB, Nelson WG. Cytidine methylation of
regulatory sequences near the pi-class glutathione S-transferase gene
accompanies human prostatic carcinogenesis. Proc Natl Acad Sci
USA 1994; 91: 11733-7.
19. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP.
CpG island methylator phenotype in colorectal cancer. Proc Natl
Acad Sci USA 1999; 96: 8681-6.
20. Carvalho B, Pinto M, Cirnes L, Oliveira C, Machado JC, Suriano G,
Hamelin R, Carneiro F, Seruca R. Concurrent hypermethylation of
gene promoters is associated with a MSI-H phenotype and diploidy
in gastric carcinomas. Eur J Cancer 2003; 39: 1222-7.
21. Nakajima T, Akiyama Y, Shiraishi J, Arai T, Yanagisawa Y, Ara M,
Fukuda Y, Sawabe M, Saitoh K, Kamiyama R, Hirokawa K, Yuasa
Y. Age-related hypermethylation of the hMLH1 promoter in gastric
cancers. Int J Cancer 2001; 94: 208-11.
22. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations
in DNA methylation: a fundamental aspect of neoplasia. Adv Can-
cer Res 1998; 72: 141-96.
23. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA
methylation in colorectal mucosa and cancer. Cancer Res 1998; 58:
5489-94.
24. Pulling LC, Divine KK, Klinge DM, Gilliland FD, Kang T, Schwartz
AG, Bocklage TJ, Belinsky SA. Promoter hypermethylation of the
O
6-methylguanine-DNA methyltransferase gene: more common in
lung adenocarcinomas from never-smokers than smokers and asso-
ciated with tumor progression. Cancer Res 2003; 63: 4842-8.
25. Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, KelseyDNA Methylation in Gastric Cancer 241
KT. Patterns of gene promoter methylation in squamous cell cancer
of the head and neck. Oncogene 2002; 21: 4231-6.
26. Bai H, Gu L, Zhou J, Deng D. p16 hypermethylation during gastric
carcinogenesis of Wistar rats by N-methyl-N -nitro-N-nitrosoguani-
dine. Mutat Res 2003; 535: 73-8.
27. Musulen E, Moreno V, Reyes G, Sancho FJ, Peinado MA, Esteller M,
Herman JG, Combalia N, Rey M, Capella G. Standardized approach
for microsatellite instability detection in gastric carcinomas. Hum
Pathol 2004; 35: 335-42.
28. Ottini L, Palli D, Falchetti M, D’Amico C, Amorosi A, Saieva C,
Calzolari A, Cimoli F, Tatarelli C, De Marchis L, Masala G, Mari-
ani-Costantini R, Cama A. Microsatellite instability in gastric can-
cer is associated with tumor location and family history in a high-
risk population from Tuscany. Cancer Res 1997; 57: 4523-9.
29. Wu MS, Lee CW, Shun CT, Wang HP, Lee WJ, Sheu JC, Lin JT.
Clinicopathological significance of altered loci of replication error
and microsatellite instability-associated mutations in gastric can-
cer. Cancer Res 1998; 58: 1494-7.
30. Yamamoto H, Perez-Piteira J, Yoshida T, Terada M, Itoh F, Imai K,
Perucho M. Gastric cancers of the microsatellite mutator phenotype
display characteristic genetic and clinical features. Gastroenterolo-
gy 1999; 116: 1348-57.
31. Kim H, Kim YH, Kim SE, Kim NG, Noh SH, Kim H. Concerted
promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin
in gastric carcinomas with microsatellite instability. J Pathol 2003;
200: 23-31.
32. Oue N, Sentani K, Yokozaki H, Kitadai Y, Ito R, Yasui W. Promot-
er methylation status of the DNA repair genes hMLH1 and MGMT
in gastric carcinoma and metaplastic mucosa. Pathobiology 2001;
69: 143-9.
′